Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 501906066

Leinco Technologies Inc Anti-Human CD11b (Mac-1, Integrin αM chain, C3biR, CR3, Mo1, ITGAM, SLEB6) In Vivo GOLD; Clone ICRF44 (44); Isotype: Mouse IgG1
SDP

Supplier:  Leinco Technologies Inc C3681.0 MG

Encompass_Preferred

Specificity: Clone ICRF44 recognizes the  subunit (CD11b) of the Human CD11b/CD18 complex. Antigen Distribution: CD11b is expressed on human peripheral blood lymphocytes, NK lymphocytes, monocytes, granulocytes, a subset of T-cells & macrophages. Background: The CD11b/CD18 antigen is a heterodimeric surface glycoprotein on leukocytes & belongs to the ß2 integrin family. CD11b (165-170 kDa) functions as a receptor for C3bi complement, clotting factor X, fibrinogen & ICAM-1. Applications: (FC, WB) Clone ICRF44 may be used to study lymphocyte subsets in flow cytometry & in cell adhesion research. It may be used to stain tissue sections which have been acetone fixed & frozen. Leinco’s In vivo GOLDTM & In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques & are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6066


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.